Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Composition Selectively Targeting BRD4 Protein with Compound PH-894

Go back to Phio Pharmaceuticals Secures U.S. Notice of Allowance for INTASYL Composition Selectively Targeting BRD4 Protein with Compound PH-894
(NASDAQ: PHIO) Delayed: 1.00 -0.01 (0.99%)
Previous Close $1.01    52 Week High
Open $1.02    52 Week Low
Day High $1.05    P/E N/A 
Day Low $0.99    EPS
Volume 206,297